Gastric antral vascular ectasia (GAVE) is a relatively rare cause of gastrointestinal (GI) bleeding that mainly affects women aged 70 years and older. Despite the obscurity of its true incidence, a ...
We determined the incidence of severe bleeding from gastric antral vascular ectasia (GAVE) after myeloablative hematopoietic cell transplant and the outcomes after treatment with endoscopic ...
Current evidence on radiofrequency ablation for gastric antral vascular ectasia raises no major safety concerns; however, evidence on its efficacy is inadequate in quantity. Therefore, this procedure ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Radiofrequency ablation has emerged as possibly being a more effective and tolerable option ...
Bleeding from gastrointestinal, vascular lesions is associated with substantial patient morbidity, frequently necessitating hospitalization and repeated blood transfusions. Although laser and ...
New Bern, N.C.-based CarolinaEast Health System has begun offering truFreeze spray cryotherapy for selected gastrointestinal conditions. The cryotherapy system, developed by Steris, enables targeted ...
Merit Medical Systems Inc. looks to ingest Pentax Medical’s C2 cryoballoon through a $22 million asset purchase expected to close Nov. 1. The C2 treats Barrett’s esophagus, which can be a precursor to ...
The patient in this case does not fit the typical demographics of GAVE due to his male gender and relatively younger age. However, his presentation of symptomatic chronic iron deficiency anemia ...
The aim of endoscopic radiofrequency ablation for gastric antral vascular ectasia (GAVE) is to ablate the dilated blood vessels and stop internal bleeding. The procedure is usually done with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results